Simultaneous quantitation of phenobarbitone and p-hydroxyphenobarbitone and their perdeuteroethyl analogues in biological fluids by combined gas chromatography-mass spectrometry.
In order to develop 5-pentadeuteroethyl-5-phenyl barbituric acid as an alternative tracer in pharmacokinetic and metabolic studies of phenobarbitone, and to search for possible isotope effects associated with such labelling, we propose a gas chromatographic-mass spectrometric assay for simultaneous measurement of phenobarbitone, p-hydroxyphenobarbitone and their perdeuteroethyl analogues, using [1,3-15N2,2-13C] phenobarbitone as internal standard. These compounds were extracted from plasma (50 microliter) or urine (500 microliter) and pentylated according to Greeley's method. Linear calibration curves were obtained in the concentration range from 0.5 to 3 micrograms/ml. The interday precision, mean accuracy and detection limit were 0.77-5.28%, 99.99-100.80% and 0.03-0.05 microgram/ml, respectively. Results for plasma and urine concentrations, and pharmacokinetic parameters in humans, are presented to illustrate this method.
Laboratoire d'Etudes Analytiques et Cinétiques du Medicament Faculté de Pharmacie, Lyon, France.
Y
Y
Benchekroun
B
B
Ribon
M
M
Desage
J L
JL
Brazier
D003903:Deuterium; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D010634:Phenobarbital / Q000031:analogs & derivatives* / Q000032:analysis* / Q000493:pharmacokinetics
C017414:4-hydroxyphenobarbital; D003903:Deuterium; D010634:Phenobarbital